Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (11855)	7/21/1998 6:33:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Vlad...Those high PE multiples for the large drug companies are like gold in their pockets.....they will use the stock value to buy the smaller companies that are selling at a lower multiple than their own.... $30-40 mill profit in 1999 and $80-100 mill profit in YR 2000 can be realized by whoever buys Vivus....20 times Vivus 1999 eps looks cheap to a company that is being valued at 30-50 times earnings.

To: VLAD who wrote (11855)	7/21/1998 7:37:00 PM
From: AlienTech	Read Replies (2) \| Respond to of 23519

>>Come on Mr. Wilson, quit holding out for $30 to $40.00/share and sell NOW before you ruin what is left of our company!!<< Gee wiz and I thought I was the only one. My only fear is that after seeing the past performance of this management team, they will screw up any buyout. In fact I am sure they already have a few. They might be trying to leverage more and everything they have done in the last month points to it, I just hope they dont get too greedy with their stock options and blow everything before its too late.